help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rivier, C.
Right arrow Articles by Vale, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rivier, C.
Right arrow Articles by Vale, W.

Endocrinology, Vol 113, 939-942, Copyright © 1983 by Endocrine Society

ARTICLES

Interaction of corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo

C Rivier and W Vale

A possible interaction between synthetic ovine corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) was tested in anesthetized and in freely moving rats. In animals whose endogenous CRF release was blocked by chlorpromazine-morphine-nembutal, AVP elicited a significantly lower maximum ACTH response than did CRF, whereas the concomitant injection of both peptides resulted in a marked potentiation of CRF-induced ACTH secretion. In freely moving rats, AVP was more potent than CRF (on an equimolar basis) in elevating plasma ACTH levels. Since immunoneutralization of endogenous CRF by the administration of anti-CRF serum significantly reduced ACTH release due to injected AVP in these animals, we suggest that at least part of the AVP-induced ACTH secretion observed in nonanesthetized rats may be due to a potentiation of endogenous CRF by exogenously administered AVP. These data support previous reports of an in vitro synergism between CRF and vasopressin, and emphasize the complex role played by the interaction of these two peptides on ACTH release in vivo.


This article has been cited by other articles:


Home page
 J EndocrinolHome page
A.-M. O'Carroll, G. M Howell, E. M Roberts, and S. J Lolait
Vasopressin potentiates corticotropin-releasing hormone-induced insulin release from mouse pancreatic {beta}-cells
J. Endocrinol., May 1, 2008; 197(2): 231 - 239.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
G. Yu, H. Chen, W. Zhao, S. G. Matta, and B. M. Sharp
Nicotine Self-Administration Differentially Regulates Hypothalamic Corticotropin-Releasing Factor and Arginine Vasopressin mRNAs and Facilitates Stress-Induced Neuronal Activation
J. Neurosci., March 12, 2008; 28(11): 2773 - 2782.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. S.-L. Gal, D. Raufaste, S. Derick, J. Blankenstein, J. Allen, B. Pouzet, M. Pascal, J. Wagnon, and M. A. Ventura
Biological characterization of rodent and human vasopressin V1b receptors using SSR-149415, a nonpeptide V1b receptor ligand
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2007; 293(2): R938 - R949.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
N. Kakui and K. Kitamura
Direct Evidence that Stimulation of Neuropeptide Y Y5 Receptor Activates Hypothalamo-Pituitary-Adrenal Axis in Conscious Rats via both Corticotropin-Releasing Factor- and Arginine Vasopressin-Dependent Pathway
Endocrinology, June 1, 2007; 148(6): 2854 - 2862.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
H. F. Figueiredo, Y. M. Ulrich-Lai, D. C. Choi, and J. P. Herman
Estrogen potentiates adrenocortical responses to stress in female rats
Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E1173 - E1182.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. Wotus, M. M. Arnhold, and W. C. Engeland
Dehydration-induced drinking decreases Fos expression in hypothalamic paraventricular neurons expressing vasopressin but not corticotropin-releasing hormone
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1349 - R1358.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Ma, M. J. Shipston, D. Morilak, and J. A. Russell
Reduced Hypothalamic Vasopressin Secretion Underlies Attenuated Adrenocorticotropin Stress Responses in Pregnant Rats
Endocrinology, March 1, 2005; 146(3): 1626 - 1637.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. C. Mantella, R. R. Vollmer, L. Rinaman, X. Li, and J. A. Amico
Enhanced corticosterone concentrations and attenuated Fos expression in the medial amygdala of female oxytocin knockout mice exposed to psychogenic stress
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1494 - R1504.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. M. Smith, J. M. Vaughan, C. J. Donaldson, J. Rivier, C. Li, A. Chen, and W. W. Vale
Cocaine- and Amphetamine-Regulated Transcript Activates the Hypothalamic-Pituitary-Adrenal Axis through a Corticotropin-Releasing Factor Receptor-Dependent Mechanism
Endocrinology, November 1, 2004; 145(11): 5202 - 5209.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. L. Rivier, D. E. Grigoriadis, and J. E. Rivier
Role of Corticotropin-Releasing Factor Receptors Type 1 and 2 in Modulating the Rat Adrenocorticotropin Response to Stressors
Endocrinology, June 1, 2003; 144(6): 2396 - 2403.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. E. Levine
Editorial: Stressing the Importance of Sex
Endocrinology, December 1, 2002; 143(12): 4502 - 4504.
[Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
C. S.-L. Gal, J. Wagnon, J. Simiand, G. Griebel, C. Lacour, G. Guillon, C. Barberis, G. Brossard, P. Soubrie, D. Nisato, et al.
Characterization of (2S,4R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V1b Receptor Antagonist
J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 1122 - 1130.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
R. L. Cole and P. E. Sawchenko
Neurotransmitter Regulation of Cellular Activation and Neuropeptide Gene Expression in the Paraventricular Nucleus of the Hypothalamus
J. Neurosci., February 1, 2002; 22(3): 959 - 969.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
S. Shridhar, A. Farley, R. L. Reid, W. G. Foster, and D. A. Van Vugt
The Effect of 2,3,7,8-Tetrachlorodibenzo-p-dioxin on Corticotrophin-Releasing Hormone, Arginine Vasopressin, and Pro-opiomelanocortin mRNA Levels in the Hypothalamus of the Cynomolgus Monkey
Toxicol. Sci., October 1, 2001; 63(2): 181 - 188.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
K. Pacak and M. Palkovits
Stressor Specificity of Central Neuroendocrine Responses: Implications for Stress-Related Disorders
Endocr. Rev., August 1, 2001; 22(4): 502 - 548.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. B. Muller, R. Landgraf, J. Preil, I. Sillaber, A. E. Kresse, M. E. Keck, S. Zimmermann, F. Holsboer, and W. Wurst
Selective Activation of the Hypothalamic Vasopressinergic System in Mice Deficient for the Corticotropin-Releasing Hormone Receptor 1 Is Dependent on Glucocorticoids
Endocrinology, November 1, 2000; 141(11): 4262 - 4269.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. K. Kim and C. L. Rivier
Nitric Oxide and Carbon Monoxide Have a Stimulatory Role in the Hypothalamic-Pituitary-Adrenal Response to Physico-Emotional Stressors in Rats
Endocrinology, June 1, 2000; 141(6): 2244 - 2253.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. W. Dent, M. A. Smith, and S. Levine
Rapid Induction of Corticotropin-Releasing Hormone Gene Transcription in the Paraventricular Nucleus of the Developing Rat
Endocrinology, May 1, 2000; 141(5): 1593 - 1598.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
S. M. Hileman, R. J. Handa, and G. L. Jackson
Distribution of Estrogen Receptor-ß Messenger Ribonucleic Acid in the Male Sheep Hypothalamus
Biol Reprod, June 1, 1999; 60(6): 1279 - 1284.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
A. V. Turnbull, J. Vaughan, J. E. Rivier, W. W. Vale, and C. Rivier
Urocortin Is Not a Significant Regulator of Intermittent Electrofootshock-Induced Adrenocorticotropin Secretion in the Intact Male Rat
Endocrinology, January 1, 1999; 140(1): 71 - 78.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Keller-Wood
ACTH responses to CRF and AVP in pregnant and nonpregnant ewes
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1998; 274(6): R1762 - R1768.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. B. Thomas, K. M. Fairhall, and I. C. A. F. Robinson
Activation of the Hypothalamo-Pituitary-Adrenal Axis by the Growth Hormone (GH) Secretagogue, GH-Releasing Peptide-6, in Rats
Endocrinology, April 1, 1997; 138(4): 1585 - 1591.
[Abstract] [Full Text] [PDF]

Home page
 J PsychopharmacolHome page
H. K. Manji, J. K. Hsiao, E. D. Risby, O. T. Osman, M. V. Rudorfer, and W. Z. Potter
ECT treatment does not enhance neuroendocrine responses to serotonergic challenge
J Psychopharmacol, January 1, 1992; 6(4): 501 - 508.
[Abstract] [PDF]

Home page
 ScienceHome page
J Axelrod and T. Reisine
Stress hormones: their interaction and regulation
Science, May 4, 1984; 224(4648): 452 - 459.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1983 by The Endocrine Society